IMO next week sometime we will see big moves with BIT.This...

IMO next week sometime we will see big moves with BIT.

This pandemic is far from over! Countries who have had both high vaccination rates and/or high previous infection and therefore natural immunity, are still seeing very high infection and transmission of each COVID variant. The only figures that matter now moving forward are hospitalisations and mortality rate, particularly the latter. Any new variant that shows an increased mortality rate will significantly increase the demand for therapeutics. With 8 billion hosts, the chances are highly likely that more harmful variants will arise.

BIT-225 has proven efficacy against the coronavirus that cause SARS, not just with COVID-19.

Big Pharma is circling, the mechanism of action of BIT-225 is different to the other therapeutics available.

It’s not long now. An announcement of the commencement of human trials will see it go to $0.13 and I strongly believe that the next announcement after that will be a sale followed by positive phase 3 data.

All IMO. GLTAH. I’m all in.